查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
机器人神经外科市场-全球和区域分析：按应用、产品类型、最终用户和区域-分析和预测（2025-2035）
市场调查报告书
商品编码
1753873

机器人神经外科市场-全球和区域分析：按应用、产品类型、最终用户和区域-分析和预测（2025-2035）

Robotic Neurosurgery Market - A Global and Regional Analysis: Focus on Application, Product Type, End User, and Regional Analysis - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 153 Pages | 商品交期: 1-5个工作天内

价格

预计2023年全球机器人神经外科手术市场规模将达3.348亿美元。

预计到2035年，该市场规模将达到22.386亿美元，在2025-2035年的预测期内，复合年增长率为16.35%。推动这一增长的关键因素包括神经系统疾病盛行率的上升，以及对先进外科手术干预的需求不断增长。精准度的提升、即时影像的整合以及人工智慧等技术创新正在改善手术效果，并拓展机器人神经外科手术的应用范围。

主要市场统计数据
预测期 2025-2035
2025年评估 4.924亿美元
2035年的预测 22.386亿美元
复合年增长率 16.35%

此外，微创手术的兴起也推动了该技术的普及，因为它缩短了患者的康復时间并降低了併发症发生率。全球医疗基础设施的不断扩张，尤其是在新兴市场，进一步推动了市场的成长。此外，研发投入的不断增加以及产业参与者之间策略联盟的建立，正在加速产品创新和市场渗透，巩​​固了机器人神经外科作为医疗保健产业关键成长领域的地位。

全球机器人神经外科市场已根据产品类型和临床应用划分为主要细分市场，以便提供清晰的分析框架和成长机会。产品类型包括机器人系统（实现精准微创手术的核心平台）以及安装、培训、维护和软体更新等基本服务，以确保系统的最佳功能。此外，由专门的手术器械和耗材组成的器械和配件对手术的成功及其持续需求起着至关重要的作用。根据应用，市场分为脊椎神经外科（主要处理与脊椎相关的疾病）和颅神经外科（专注于与大脑和颅骨相关的手术）。按地区划分，市场正在北美、欧洲、亚太地区和世界其他地区扩张。这种细分使行业相关人员能够了解趋势、有效分配资源并客製化技术创新以满足不同外科学科的特定需求，从而利用区域成长。

影响分析：

机器人神经外科手术市场正在产生以下影响：

  • 提高手术精度：机器人系统大大提高了复杂神经外科手术的精确度，从而降低风险并改善患者的治疗效果。
  • 微创技术：使用机器人技术可以实现微创手术，从而缩短恢復时间、减少併发症并降低医疗成本。
  • 扩大获得高级护理的机会：随着机器人技术的引入，全球更多医疗机构（包括医疗服务不足的地区）现在可以提供尖端神经外科护理。
  • 技术创新和市场成长：不断的技术进步和不断增加的投资正在加速新机器人平台和设备的发展，推动市场的强劲扩张。

市场区隔:

细分 1：按产品类型

  • 机器人系统
  • 服务
  • 设备和配件

仪器和配件部分继续主导机器人神经外科市场（按产品类型）

根据产品类型，机器人脑外科手术市场以仪器和配件为主导，到 2023 年将占据 51.48% 的份额。

细分2：按应用

  • 脊椎神经外科
  • 颅脑神经外科

脊椎神经外科领域将继续主导机器人神经外科市场（按应用）

根据应用，机器人神经外科市场以脊椎神经外科为主导，到 2023 年将占 73.51% 的份额。

细分 3：按最终用户

  • 医院
  • 门诊手术中心

医院部门将继续主导机器人神经外科手术市场（按最终用户划分）

根据最终用户来看，机器人神经外科手术市场由医院主导，2023 年的份额为 91.90%。

细分4：按地区

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 法国
  • 义大利
  • 西班牙
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 日本
  • 印度
  • 韩国
  • 澳洲
  • 其他亚太国家
  • 其他地区

2023年，亚太地区机器人神经外科手术市场由中国主导，这得益于几个关键因素。这些因素包括医疗基础设施的快速发展、政府对医疗技术应用的大力支持，以及神经系统疾病盛行率不断上升的庞大患者群体。此外，研发投入的不断增加以及人们对微创手术技术的认知和接受度的不断提高，也推动了对机器人神经外科手术系统的需求。国内领先製造商的涌现以及与全球技术提供商的战略合作伙伴关係，进一步巩固了中国在该区域市场的主导地位。

机器人神经外科手术市场的最新趋势

  • 2025年4月，脑导航生物科技股份有限公司宣布与第一证券公司开始进行首次股票公开发行（IPO）辅导。
  • 2025年3月，神经外科机器人领域的先驱－脑导航生物科技公司宣布与明基医疗科技建立策略伙伴关係，在中国推出并商业化神经外科导航机器人「NaoTrac」。此次合作将支持脑导航生物科技公司2025年的全球化策略，该策略专注于本地伙伴关係，以加快市场进入速度并促进临床应用。
  • 2024 年 8 月，MMI（Medical Microinstruments, Inc.）宣布成功完成临床前试验，以确认 Symani 手术系统在神经外科手术中的可行性。
  • 2024 年 5 月，AiM Medical Robotics Inc. 宣布与布莱根妇女医院 (BWH) 和哈佛大学手术导航和机器人 (SNR) 实验室合作，检验用于帕金森氏症患者深部脑部刺激治疗的先进机器人。
  • 2024 年 5 月，Monteris Medical Corporation 宣布推出专为机器人辅助 NeuroBlate 系统设计的 NeuroBlate NB3 FullFire 1.6mm 雷射探头。

需求——驱动因素与限制因素

市场需求驱动因素：

  • 机器人神经外科手术相较于传统开放性手术的优势：机器人辅助神经外科手术相比传统开放性手术具有显着优势，已成为现代医学的颠覆性技术。分析师认为，这些系统是一项重大进步，因为它们提高了手术的精确度和准确度，能够更精准地定位大脑和脊髓的关键区域，从而降低损伤健康组织的风险。机器人手术的微创特性使其切口更小、失血量更少、恢復时间更快、住院时间更短，最终改善病患的预后并降低医疗成本。

此外，机器人系统还能降低传统开放性手术中常见的脑肿胀、出血和感染疾病等併发症的发生率。由于机器人平台拥有卓越的灵活性和3D视觉化功能，外科医生也能从更高的效率、更强的控制力和更舒适的体验中受益。凭藉这些优势，对机器人神经外科日益增长的需求正在重塑该领域，为患者提供更安全、更有效的治疗，同时降低医疗机构的成本。随着技术的不断发展，分析师预测，机器人神经外科将成为各种神经外科手术的标准治疗方案。

  • 神经系统疾病发生率上升：神经系统疾病发生率上升是影响机器人神经外科市场扩张的重要因素。随着对先进和微创手术选择的需求不断增长，机器人系统将在现代神经外科实践中发挥关键作用，从而改善患者照护和手术效率。根据发表在《刺胳针神经病学》上的一项研究，神经系统疾病是全球疾病和残疾的主要原因，2021 年影响约 340 万人。这是过去三十年来的显着增长，伤残调整生命年 (DALY) 从 1990 年到 2021 年增加了 18%。造成这项负担的主要因素包括中风、新生儿脑病变、偏头痛、阿兹海默症失智症和糖尿病神经病变。值得注意的是，神经发育和儿科疾病占全球整体负担的近20%，导致2021年健康寿命损失8,000万年。

神经系统疾病发生率上升的因素包括人口老化、预期寿命延长以及环境、代谢和生活方式风险因素的影响。令人担忧的是，超过80%的神经系统疾病死亡和健康损失发生在中低收入国家，凸显了巨大的健康差距。本研究强调了实施有效的预防、治疗、復健和长期照护策略以应对这一日益严重的公共卫生问题的重要性。

此类神经系统疾病的盛行率不断上升，是机器人神经外科市场的主要驱动力。对有效微创治疗方案的需求日益增长，推动了机器人辅助神经外科的普及。与传统的开放性手术相比，这些技术具有更高的精确度、更少的併发症和更快的恢復时间，使其成为现代神经外科实践的重要组成部分。

市场限制：

  • 高昂的投资成本：实施神经外科机器人的高昂成本是许多医疗机构面临的经济障碍，阻碍了这项创新技术的广泛应用。机器人系统所需的初始投资，以及持续的维护、培训和营运成本，构成了巨大的预算挑战，尤其对于规模较小的医院或财力有限的医院而言。在考虑机器人系统时，医院必须仔细评估整体拥有成本，不仅要考虑初始购买价格，还要考虑长期营运成本。

市场机会：

  • 远距手术机器人系统的发展：远距手术机器人系统的发展为机器人神经外科市场创造了巨大的机会。透过实现远端存取专科神经外科护理，这些系统可以克服地理障碍，改善医疗资源匮乏地区和农村地区的医疗服务。先进机器人技术、即时通讯和人工智慧的融合，提高了手术精度，缩短了恢復时间，并为医院提供了经济高效的解决方案。此外，世界各地的外科医生可以进行远端培训和协作，从而促进持续创新和知识共用，进一步加速机器人系统的普及。随着技术的不断发展，远距机器人神经外科手术的可能性将不断扩大，推动市场成长，并重塑全球外科护理的未来。

产品/创新策略：全球机器人神经外科市场已根据产品类型、应用、最终用户、地区等不同类别进行广泛细分。这有助于读者清楚了解哪个细分市场占有最大份额以及哪个细分市场可能在未来几年内成长。

成长/行销策略：2022 年 1 月至 2025 年 4 月期间，新产品占据全球机器人神经外科市场关键发展的最大份额。

竞争策略：全球机器人神经外科市场拥有许多参与企业，并拥有各自的产品和服务组合。本研究分析并概述了全球机器人神经外科市场的主要企业，包括提供机器人神经外科系统、器械、配件和服务的现有企业。

本报告研究了全球机器人神经外科市场，并概述了市场趋势以及应用、产品类型、最终用户、地区和参与市场的公司概况。

目录

执行摘要

第一章全球机器人神经外科市场：产业展望

  • 趋势：现况与未来影响评估
    • 机器人神经外科手术的采用率不断提高
    • 市场参与企业之间的众多合作
    • 增加产品发布和监管核准
  • 供应链概览
  • 法律规范
    • 美国
    • 欧洲联盟
    • 英国
    • 日本
    • 中国
    • 其他地区
  • 赎回方案
    • 美国报销情况
  • 专利分析
    • 专利申请趋势（按国家和年份）
  • 定价分析
  • 案例研究
  • 资金筹措方案
  • 市场动态

2. 全球机器人神经外科市场（依产品类型），百万美元，2023-2035

  • 机器人系统
  • 设备和配件
  • 服务

3. 全球机器人神经外科市场（按应用），百万美元，2023-2035 年

  • 脊椎和神经外科
  • 颅脑神经外科

4. 全球机器人神经外科市场（按最终用户划分），百万美元，2023-2035 年

  • 医院
  • 门诊手术中心

5. 全球机器人神经外科市场（按地区划分），百万美元，2023 年至 2035 年

  • 区域摘要
  • 北美洲
    • 区域概况
    • 市场成长动力
    • 成长抑制因素
    • 手术次数
    • 美国
    • 加拿大
  • 欧洲
    • 区域概况
    • 市场成长动力
    • 成长抑制因素
    • 手术次数
    • 德国
    • 西班牙
    • 英国
    • 其他的
  • 亚太地区
    • 区域概况
    • 市场成长动力
    • 成长抑制因素
    • 手术次数
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 其他的
  • 其他地区
    • 区域概况
    • 市场成长动力
    • 成长抑制因素
    • 手术次数

第六章 市场-产品概况

  • Medtronic plc
  • Globus Medical, Inc.
  • Renishaw plc
  • Zimmer Biomet Holdings, Inc.

7. 市场竞争基准化分析与公司概况

  • 产品基准
  • 关键策略和发展
  • 公司简介
    • Brainlab AG
    • Renishaw plc
    • Globus Medical, Inc.
    • Zimmer Biomet Holdings, Inc.
    • Medical Microinstruments, Inc.
    • Monteris Medical Corporation
    • Medtronic plc
    • Accuray Incorporated
    • AiM Medical Robotics
    • KUKA AG (Midea Group)
    • Beijing Baihui Weikang Technology Co., Ltd.
    • Brain Navi Biotechnology Co. Ltd
    • Beijing Tinavi Medical Technologies Co., Ltd.

第八章调查方法

Product Code: BHR3021SA

This report can be delivered within 1 working day.

Introduction to Robotic Neurosurgery Market

The global robotic neurosurgery market is projected to reach $2,238.6 million in 2035 and estimated $334.8 million in 2023, growing at a CAGR of 16.35% during the forecast period 2025-2035. Key factors driving this growth include the rising prevalence of neurological disorders, which increases the demand for advanced surgical interventions. Technological innovations, including improved precision, the integration of real-time imaging, and AI-enabled capabilities, are enhancing surgical outcomes and broadening the scope of robotic neurosurgery.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$492.4 Million
2035 Forecast$2,238.6 Million
CAGR16.35%

Additionally, the shift toward minimally invasive procedures has been fueling adoption by reducing patient recovery times and complication rates. The expansion of healthcare infrastructure worldwide, particularly in emerging markets, further supports market growth. Moreover, increased investment in research and development, coupled with strategic collaborations among industry players, has been accelerating product innovation and market penetration, solidifying robotic neurosurgery's role as a key growth sector in the healthcare industry.

Market Introduction

The global robotic neurosurgery market is categorized into key segments based on product type and clinical application to provide a clear framework for analysis and growth opportunities. Product types include robotic systems, the core platforms that enable precise and minimally invasive surgeries, alongside essential services such as installation, training, maintenance, and software updates that ensure optimal system functionality. Additionally, instruments and accessories, comprising specialized surgical tools and consumables, play a critical role in procedure success and ongoing demand. On the application side, the market is primarily divided into spinal neurosurgery, which addresses conditions related to the spine, and cranial neurosurgery, focused on brain and skull-related procedures. Geographically, the market has been expanding across regions including North America, Europe, Asia-Pacific, and the Rest-of-the-World. This segmentation enables industry stakeholders to identify trends, allocate resources effectively, and tailor innovations to meet the specific needs of different surgical domains, thereby capitalizing on regional growth.

Impact Analysis:

The robotic neurosurgery market has made an impact in the following ways:

  • Enhanced Surgical Precision: Robotic systems have significantly improved the accuracy of complex neurosurgical procedures, thereby reducing risks and enhancing patient outcomes.
  • Minimally Invasive Techniques: The adoption of robotics has enabled less invasive surgeries, leading to shorter recovery times, reduced complications, and lower healthcare costs.
  • Expanded Access to Advanced Care: Robotics has facilitated the availability of cutting-edge neurosurgical interventions in more healthcare facilities worldwide, including underserved regions.
  • Innovation and Market Growth: Continuous technological advancements and increased investments have accelerated the development of new robotic platforms and instruments, driving robust market expansion.

Market Segmentation:

Segmentation 1: by Product Type

  • Robotic Systems
  • Services
  • Instruments and Accessories

Instruments and Accessories Segment to Continue Dominating the Robotic Neurosurgery Market (by Product Type)

Based on product type, the robotic neurosurgery market is led by instrument and accessories, which held a 51.48% share in 2023.

Segmentation 2: by Application

  • Spinal Neurosurgery
  • Cranial Neurosurgery

Spinal Neurosurgery Segment to Continue Dominating the Robotic Neurosurgery Market (by Application)

Based on application, the robotic neurosurgery market is led by spinal neurosurgery, which held a 73.51% share in 2023.

Segmentation 3: by End User

  • Hospitals
  • Ambulatory Surgical Centers

Hospitals Segment to Continue Holding its Dominance in the Robotic Neurosurgery Market (by End User)

Based on end users, the robotic neurosurgery market is led by hospitals, which held a 91.90% share in 2023.

Segmentation 4: by Region

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Rest-of-Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest-of-Asia-Pacific
  • Rest-of-the-World

China dominated the Asia-Pacific robotic neurosurgery market in 2023, driven by several key factors. These include rapid advancements in healthcare infrastructure, strong government support for the adoption of medical technology, and a large patient population with a rising prevalence of neurological disorders. Additionally, increasing investments in research and development, coupled with growing awareness and acceptance of minimally invasive surgical techniques, have fueled demand for robotic neurosurgery systems. The presence of leading domestic manufacturers and strategic partnerships with global technology providers further strengthen China's leadership position in the regional market.

Recent Developments in the Robotic Neurosurgery Market

  • In April 2025, Brain Navi Biotechnology Co., Ltd. announced the commencement of its initial public offering (IPO) counseling with First Securities Inc., a significant move toward tapping into the capital markets to fuel its long-term growth in the surgical robot technology sector.
  • In March 2025, Brain Navi Biotechnology, a pioneer in neurosurgical robotics, revealed a strategic partnership with BenQ Medical Technology to launch and commercialize the NaoTrac neurosurgical navigation robot in China. This collaboration supports Brain Navi's 2025 globalization strategy, focusing on localized partnerships to expedite market entry and boost clinical adoption.
  • In August 2024, MMI (Medical Microinstruments, Inc.) announced the successful completion of a preclinical study that confirmed the feasibility of the Symani Surgical System for neurosurgical procedures.
  • In May 2024, AiM Medical Robotics Inc. announced a collaboration with Brigham and Women's Hospital (BWH) and the Surgical Navigation and Robotics (SNR) Lab at Harvard to validate their advanced robot for deep brain stimulation in Parkinson's patients.
  • In May 2024, Monteris Medical Corporation announced the release of the NeuroBlate NB3 FullFire 1.6mm laser probe, designed for use with their robotic-assisted NeuroBlate system.

Demand - Drivers and Limitations

Market Demand Drivers:

  • Advantages of Robotic Neurosurgical Procedures Over Conventional Open Surgical Procedures: Robotic-assisted neurosurgical procedures offer significant advantages over conventional open surgeries, making them a game-changer in modern medicine. Analysts view these systems as a major advancement due to their enhanced precision and accuracy, which allows for more accurate targeting of critical brain and spinal areas, reducing the risk of damaging healthy tissues. The minimally invasive nature of robotic surgeries results in smaller incisions, reduced blood loss, faster recovery times, and shorter hospital stays, ultimately improving patient outcomes and lowering healthcare costs.

Additionally, robotic systems reduce the likelihood of complications such as brain swelling, bleeding, and infections, which are common in traditional open surgeries. Surgeons also benefit from improved efficiency, greater control, and enhanced comfort, as robotic platforms offer superior dexterity and 3D visualization. With these advantages, the growing demand for robotic neurosurgery has been reshaping the field, offering patients safer, more effective treatments while driving cost savings for healthcare providers. As technology continues to evolve, analysts predict that robotic neurosurgery will become the standard of care for a wide range of neurological procedures.

  • Rising Prevalence of Neurological Disorders: The rising incidence of neurological conditions has been significantly influencing the expansion of the robotic neurosurgery market. As the demand for advanced, minimally invasive surgical options continues to grow, robotic systems are poised to play a crucial role in modern neurosurgical practices, thereby enhancing patient care and surgical efficiency. The study published in The Lancet Neurology reveals that neurological conditions have become the leading cause of ill health and disability globally, affecting approximately 3.4 million people in 2021. This marks a significant increase over the past three decades, with the number of disability-adjusted life years (DALYs) rising by 18% from 1990 to 2021. The primary contributors to this burden include stroke, neonatal encephalopathy, migraine, Alzheimer's disease and other dementias, and diabetic neuropathy. Notably, neurodevelopmental and pediatric conditions accounted for nearly 20% of the total neurological burden worldwide, equating to 80 million years of healthy life lost in 2021.

The rise in neurological disorders is attributed to factors such as population aging, increased life expectancy, and exposure to environmental, metabolic, and lifestyle risk factors. Alarmingly, over 80% of neurological deaths and health loss occur in low- and middle-income countries, underscoring significant health disparities. The study highlights the importance of implementing effective prevention, treatment, rehabilitation, and long-term care strategies to address this growing public health issue.

This escalating prevalence of neurological conditions is a key driver for the robotic neurosurgery market. The increasing demand for effective and minimally invasive treatment options has spurred the adoption of robotic-assisted neurosurgical procedures. These technologies offer enhanced precision, reduced complications, and shorter recovery times compared to traditional open surgeries, positioning them as a critical component in modern neurosurgical practices.

Market Restraints:

  • High Cost of Investment: The high cost of acquiring neurosurgery robots presents a significant financial hurdle for many healthcare institutions, hindering the widespread adoption of this transformative technology. The initial investment required for robotic systems, along with ongoing maintenance, training, and operational costs, can create a considerable budgetary challenge, particularly for smaller hospitals or those with limited financial resources. As hospitals look to integrate robotic systems, they must carefully assess the total cost of ownership, factoring in not only the upfront purchase price but also the long-term operational expenses.

Market Opportunities:

  • Development of Long-Distance Teleoperated Surgical Robotic Systems: The development of long-distance teleoperated surgical robotic systems presents a significant opportunity for the robotic neurosurgery market. By enabling remote access to specialized neurosurgical care, these systems can overcome geographical barriers, improving healthcare access in underserved and rural regions. The integration of advanced robotics, real-time communication, and artificial intelligence enhances surgical precision, reduces recovery times, and offers cost-effective solutions for hospitals. Moreover, the ability to provide remote training and collaboration among surgeons worldwide fosters continuous innovation and knowledge sharing, further accelerating the adoption of robotic systems. As technology continues to evolve, the potential for long-distance robotic neurosurgery will expand, driving market growth and reshaping the future of surgical care globally.

How can this report add value to an organization?

Product/Innovation Strategy: The global robotic neurosurgery market has been extensively segmented based on various categories, such as product type, application, end user, and region. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Growth/Marketing Strategy: The new offering accounted for the maximum number of key developments in the global robotic neurosurgery market between January 2022 and April 2025.

Competitive Strategy: The global robotic neurosurgery market has numerous established players with product and service portfolios. Key players in the global robotic neurosurgery market, as analyzed and profiled in the study, include established companies offering robotic neurosurgery systems, instruments, accessories, and services.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • Detailed secondary research was performed to ensure maximum coverage of manufacturers/suppliers operational in a country.
  • Exact revenue information, up to a certain extent, was extracted for each company from secondary sources and databases. The revenues specific to the offering, application, end user, and region were then estimated for each market player based on fact-based proxy indicators, as well as primary inputs.
  • The scope of this report has been carefully derived based on interactions with experts in different companies across the world. This report provides a market study of robotic neurosurgery.
  • The market contribution of robotic neurosurgery, anticipated to be launched in the future, has been calculated based on historical analysis. This analysis has been supported by proxy factors, including the innovation scale of the companies, funding status, collaborations, customer base, and patent scenario.
  • The scope of availability of robotic neurosurgery products and services in a particular region has been assessed through a comprehensive analysis of companies' prospects, regional end-user perceptions, and other factors influencing the launch of robotic neurosurgery products and services in that region.
  • The base year considered for the calculation of the market size is 2024. A historical year analysis has been done for the period FY2021-FY2023. The market size has been estimated for FY2024 and projected for the period from FY2025 to FY2035.
  • Revenues of the companies have been referenced from their annual reports for FY2021-FY2024. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, product approval status, market collaborations, and operational history.
  • The regional distribution of market revenue has been estimated based on the number of companies in each region and the adoption rate of robotic neurosurgery. All the numbers have been adjusted to a single digit after the decimal for better presentation in the report. However, the real figures have been utilized for compound annual growth rate (CAGR) estimation. The CAGR has been calculated for the period 2025-2035.
  • The market has been mapped based on the available robotic neurosurgery. All the key companies with significant offerings in this field have been considered and profiled in this report.
  • Market strategies and developments of key players have been taken into account for calculating the market potential in the forecast period.

Primary Research:

The primary sources involve industry experts in the robotic neurosurgery market, including the market players offering robotic neurosurgery solutions. Resources, including CXOs, vice presidents, product managers, directors, territory managers, and business development professionals, have been interviewed to gather and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

  • Validation and triangulation of all the numbers and graphs
  • Validation of the report's segmentation and key qualitative findings for robotic neurosurgery
  • Understanding the competitive landscape and business model
  • Current and proposed production values of a product by market players
  • Validation of the numbers of the different segments of the market in focus
  • Percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • European Medicines Agency (EMA), American Chemical Society (ACS), Frontiers, World Health Organization (WHO), and National Center for Biotechnology Information (NCBI), among others
  • Annual reports, SEC filings, and investor presentations of the leading market players
  • Company websites and detailed study of their portfolios
  • Gold standard magazines, journals, whitepapers, press releases, and news articles
  • Databases

The key data points taken from the secondary sources include:

  • Segmentation and percentage share estimates
  • Company and country understanding and data for market value estimation
  • Key industry/market trends
  • Developments among top players
  • Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, type portfolio, and market penetration.

Some prominent names in the global robotic neurosurgery market include:

  • Brainlab AG
  • Renishaw plc
  • Zimmer Biomet Holding, Inc.
  • Medical Microinstruments, Inc.
  • Monteris Medical Corporation
  • Medtronic plc.
  • Globus Medical Inc.
  • Accuray Incorporated

Table of Contents

Executive Summary

Scope and Definition

1 Global Robotic Neurosurgery Market: Industry Outlook

  • 1.1 Trends: Current and Future Impact Assessment
    • 1.1.1 Increasing Adoption of Robotic Neurosurgery Procedures
    • 1.1.2 Significant Number of Collaborations among Market Players
    • 1.1.3 Growing Number of Product Launch and Regulatory Approvals
  • 1.2 Supply Chain Overview
  • 1.3 Regulatory Framework
    • 1.3.1 U.S.
    • 1.3.2 European Union (EU)
    • 1.3.3 U.K.
    • 1.3.4 Japan
    • 1.3.5 China
    • 1.3.6 Rest-of-the-World (RoW)
  • 1.4 Reimbursement Scenario
    • 1.4.1 Reimbursement Scenario in the U.S.
  • 1.5 Patent Analysis
    • 1.5.1 Patent Filing Trend (by Country, Year)
  • 1.6 Pricing Analysis
  • 1.7 Case Studies
    • 1.7.1 Case Study: First Use of Mazor X Stealth Edition Robotic Guidance Platform at an Outpatient Surgery Center in Ohio
    • 1.7.2 Case Study: Brain Navi's NaoTrac Reaches 100 Neurosurgical Procedures Milestone
  • 1.8 Funding Scenario
  • 1.9 Market Dynamics
    • 1.9.1 Market Drivers
      • 1.9.1.1 Advantages of Robotic Neurosurgical Procedures Over Conventional Open Surgical Procedures
      • 1.9.1.2 Rising Prevalence of Neurological Disorders
      • 1.9.1.3 Continuous Technological Advancements in Robotic Neurosurgery
    • 1.9.2 Market Restraints
      • 1.9.2.1 High Cost of Investment
      • 1.9.2.2 Lack of Skilled Professionals
    • 1.9.3 Market Opportunities
      • 1.9.3.1 Development of Long-Distance Teleoperated Surgical Robotic Systems

2 Global Robotic Neurosurgery Market (by Product Type), $Million, 2023-2035

  • 2.1 Robotic Systems
  • 2.2 Instruments and Accessories
  • 2.3 Services

3 Global Robotic Neurosurgery Market (by Application), $Million, 2023-2035

  • 3.1 Spinal Neurosurgery
  • 3.2 Cranial Neurosurgery

4 Global Robotic Neurosurgery Market (by End User), $Million, 2023-2035

  • 4.1 Hospitals
  • 4.2 Ambulatory Surgical Centers

5 Global Robotic Neurosurgery Market (by Region), $Million, 2023-2035

  • 5.1 Regional Summary
  • 5.2 North America
    • 5.2.1 Regional Overview
    • 5.2.2 Driving Factors for Market Growth
    • 5.2.3 Factors Challenging the Market
    • 5.2.4 Procedure Volume
    • 5.2.5 U.S.
    • 5.2.6 Canada
  • 5.3 Europe
    • 5.3.1 Regional Overview
    • 5.3.2 Driving Factors for Market Growth
    • 5.3.3 Factors Challenging the Market
    • 5.3.4 Procedure Volume
    • 5.3.5 Germany
    • 5.3.6 Spain
    • 5.3.7 U.K.
    • 5.3.8 Rest-of-Europe
  • 5.4 Asia-Pacific
    • 5.4.1 Regional Overview
    • 5.4.2 Driving Factors for Market Growth
    • 5.4.3 Factors Challenging the Market
    • 5.4.4 Procedure Volume
    • 5.4.5 China
    • 5.4.6 Japan
    • 5.4.7 India
    • 5.4.8 Australia
    • 5.4.9 South Korea
    • 5.4.10 Rest-of-Asia-Pacific
  • 5.5 Rest-of-the-World
    • 5.5.1 Regional Overview
    • 5.5.2 Driving Factors for Market Growth
    • 5.5.3 Factors Challenging the Market
    • 5.5.4 Procedure Volume

6 Markets - Product Profiles

  • 6.1 Medtronic plc
    • 6.1.1 Product Overview
    • 6.1.2 Launch Year
    • 6.1.3 Key Features
    • 6.1.4 Key Parameter
    • 6.1.5 Installed Base
    • 6.1.6 Unit Sold
  • 6.2 Globus Medical, Inc.
    • 6.2.1 Product Overview
    • 6.2.2 Launch Year
    • 6.2.3 Key Features
    • 6.2.4 Key Parameter
    • 6.2.5 Installed Base
    • 6.2.6 Unit Sold
  • 6.3 Renishaw plc
    • 6.3.1 Product Overview
    • 6.3.2 Launch Year
    • 6.3.3 Key Features
    • 6.3.4 Key Parameter
    • 6.3.5 Installed Base
    • 6.3.6 Unit Sold
  • 6.4 Zimmer Biomet Holdings, Inc.
    • 6.4.1 Product Overview
    • 6.4.2 Launch Year
    • 6.4.3 Key Features
    • 6.4.4 Key Parameter
    • 6.4.5 Installed Base
    • 6.4.6 Unit Sold

7 Markets - Competitive Benchmarking & Company Profiles

  • 7.1 Product Benchmarking
  • 7.2 Key Strategies and Development
  • 7.3 Company Profiles
    • 7.3.1 Brainlab AG
      • 7.3.1.1 Overview
      • 7.3.1.2 Top Products/Product Portfolio
      • 7.3.1.3 Top Competitors
      • 7.3.1.4 Target Customers
      • 7.3.1.5 Key Personal
      • 7.3.1.6 Analyst View
    • 7.3.2 Renishaw plc
      • 7.3.2.1 Overview
      • 7.3.2.2 Top Products/Product Portfolio
      • 7.3.2.3 Top Competitors
      • 7.3.2.4 Target Customers
      • 7.3.2.5 Key Personal
      • 7.3.2.6 Analyst View
    • 7.3.3 Globus Medical, Inc.
      • 7.3.3.1 Overview
      • 7.3.3.2 Top Products/Product Portfolio
      • 7.3.3.3 Top Competitors
      • 7.3.3.4 Target Customers
      • 7.3.3.5 Key Personal
      • 7.3.3.6 Analyst View
    • 7.3.4 Zimmer Biomet Holdings, Inc.
      • 7.3.4.1 Overview
      • 7.3.4.2 Top Products/Product Portfolio
      • 7.3.4.3 Top Competitors
      • 7.3.4.4 Target Customers
      • 7.3.4.5 Key Personal
      • 7.3.4.6 Analyst View
    • 7.3.5 Medical Microinstruments, Inc.
      • 7.3.5.1 Overview
      • 7.3.5.2 Top Products/Product Portfolio
      • 7.3.5.3 Top Competitors
      • 7.3.5.4 Target Customers
      • 7.3.5.5 Key Personal
      • 7.3.5.6 Analyst View
    • 7.3.6 Monteris Medical Corporation
      • 7.3.6.1 Overview
      • 7.3.6.2 Top Products/Product Portfolio
      • 7.3.6.3 Top Competitors
      • 7.3.6.4 Target Customers
      • 7.3.6.5 Key Personal
      • 7.3.6.6 Analyst View
    • 7.3.7 Medtronic plc
      • 7.3.7.1 Overview
      • 7.3.7.2 Top Products/Product Portfolio
      • 7.3.7.3 Top Competitors
      • 7.3.7.4 Target Customers
      • 7.3.7.5 Key Personal
      • 7.3.7.6 Analyst View
    • 7.3.8 Accuray Incorporated
      • 7.3.8.1 Overview
      • 7.3.8.2 Top Products/Product Portfolio
      • 7.3.8.3 Top Competitors
      • 7.3.8.4 Target Customers
      • 7.3.8.5 Key Personal
      • 7.3.8.6 Analyst View
    • 7.3.9 AiM Medical Robotics
      • 7.3.9.1 Overview
      • 7.3.9.2 Top Products/Product Portfolio
      • 7.3.9.3 Top Competitors
      • 7.3.9.4 Target Customers
      • 7.3.9.5 Key Personal
      • 7.3.9.6 Analyst View
    • 7.3.10 KUKA AG (Midea Group)
      • 7.3.10.1 Overview
      • 7.3.10.2 Top Products/Product Portfolio
      • 7.3.10.3 Top Competitors
      • 7.3.10.4 Target Customers
      • 7.3.10.5 Key Personal
      • 7.3.10.6 Analyst View
    • 7.3.11 Beijing Baihui Weikang Technology Co., Ltd.
      • 7.3.11.1 Overview
      • 7.3.11.2 Top Products/Product Portfolio
      • 7.3.11.3 Top Competitors
      • 7.3.11.4 Target Customers
      • 7.3.11.5 Key Personal
      • 7.3.11.6 Analyst View
    • 7.3.12 Brain Navi Biotechnology Co. Ltd
      • 7.3.12.1 Overview
      • 7.3.12.2 Top Products/Product Portfolio
      • 7.3.12.3 Top Competitors
      • 7.3.12.4 Target Customers
      • 7.3.12.5 Key Personal
      • 7.3.12.6 Analyst View
    • 7.3.13 Beijing Tinavi Medical Technologies Co., Ltd.
      • 7.3.13.1 Overview
      • 7.3.13.2 Top Products/Product Portfolio
      • 7.3.13.3 Top Competitors
      • 7.3.13.4 Target Customers
      • 7.3.13.5 Key Personal
      • 7.3.13.6 Analyst View

8 Research Methodology

  • 8.1 Data Sources
    • 8.1.1 Primary Data Sources
    • 8.1.2 Secondary Data Sources
    • 8.1.3 Data Triangulation
  • 8.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Global Robotic Neurosurgery Market (by Scenario), $Million, 2024, 2028, and 2035
  • Figure 2: Global Robotic Neurosurgery Market, $Million, 2023 and 2035
  • Figure 3: Robotic Neurosurgery Market (by End User), $Million, 2023, 2028, and 2035
  • Figure 4: Robotic Neurosurgery Market (by Product Type), $Million, 2023, 2028, and 2035
  • Figure 5: Robotic Neurosurgery Market (by Application), $Million, 2023, 2028, and 2035
  • Figure 6: Robotic Neurosurgery Literature Published, January 2015 to April 2025
  • Figure 7: Robotic Neurosurgery Market Segmentation
  • Figure 8: Supply Chain and Risks within the Supply Chain
  • Figure 9: FDA Classification
  • Figure 10: EU Classification
  • Figure 11: NHS Classification
  • Figure 12: Japan Federation of Medical Devices Associations (JFMDA) Classification
  • Figure 13: NMPA Classification
  • Figure 14: Organization of the Health System in the U.S.
  • Figure 15: Global Robotic Neurosurgery Market, Patent Analysis (by Country), January 2019-April 2025
  • Figure 16: Global Robotic Neurosurgery Market, Patent Analysis (by Year), January 2019-April 2025
  • Figure 17: Impact Analysis of Market Navigating Factors, 2024-2035
  • Figure 18: Global Incidences of Neurological Disorders, Thousands, 2018-2021
  • Figure 19: Global Prevalence of Neurological Disorders (by Type of Neurological Disease), Thousands, 1990-2019
  • Figure 20: Prevalence of Parkinson's Disease, Region (2016-2021)
  • Figure 21: Timeline of the FDA Approvals for Various Robotic Neurosurgery Systems
  • Figure 22: Global Robotic Neurosurgery Market (by Product Type), $Million, 2023, 2028, and 2035
  • Figure 23: Global Robotic Neurosurgery Market, Robotic Systems, $Million, 2023-2035
  • Figure 24: Global Robotic Neurosurgery Market, Instruments and Accessories, $Million, 2023-2035
  • Figure 25: Global Robotic Neurosurgery Market, Services, $Million, 2023-2035
  • Figure 26: Global Robotic Neurosurgery Market (by Application), 2023, 2028, and 2035
  • Figure 27: Global Robotic Neurosurgery Market, Spinal Neurosurgery,$Million, 2023-2035
  • Figure 28: Global Robotic Neurosurgery Market, Cranial Neurosurgery,$Million, 2023-2035
  • Figure 29: Global Robotic Neurosurgery Market (by End User), $Million, 2023, 2028, and 2035
  • Figure 30: Global Robotic Neurosurgery Market, Hospitals, $Million, 2023-2035
  • Figure 31: Global Robotic Neurosurgery Market, Ambulatory Surgical Centers, $Million, 2023-2035
  • Figure 32: North America Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 33: North America Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 34: North America Robotic Neurosurgery Market, Installed Base, 2023-2035
  • Figure 35: North America Robotic Neurosurgery Market, Unit Sold, 2023-2035
  • Figure 36: Incidences of Neurological Disorders in U.S., 2018-2021
  • Figure 37: U.S. Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 38: U.S. Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 39: Incidences of Neurological Disorders in Canada, 2018-2021
  • Figure 40: Canada Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 41: Canada Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 42: Europe Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 43: Europe Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 44: Europe Robotic Neurosurgery Market, Installed Base, 2023-2035
  • Figure 45: Europe Robotic Neurosurgery Market, Unit Sold, 2023-2035
  • Figure 46: Incidences of Neurological Disorders in Germany, 2018-2021
  • Figure 47: Germany Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 48: Germany Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 49: Incidences of Neurological Disorders in France, 2018-2021
  • Figure 50: France Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 51: France Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 52: Incidences of Neurological Disorders in Italy, 2018-2021
  • Figure 53: Italy Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 54: Italy Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 55: Incidences of Neurological Disorders in Spain, 2018-2021
  • Figure 56: Spain Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 57: Spain Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 58: Incidences of Neurological Disorders in U.K., 2018-2021
  • Figure 59: U.K. Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 60: U.K. Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 61: Rest-of-Europe Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 62: Rest-of-Europe Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 63: Asia-Pacific Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 64: Asia-Pacific Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 65: Asia-Pacific Robotic Neurosurgery Market, Installed Base, 2023-2035
  • Figure 66: Asia-Pacific Robotic Neurosurgery Market, Unit Sold, 2023-2035
  • Figure 67: Incidences of Neurological Disorders in China, 2018-2021
  • Figure 68: China Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 69: China Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 70: Incidences of Neurological Disorders in Japan, 2018-2021
  • Figure 71: Japan Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 72: Japan Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 73: Incidences of Neurological Disorders in India, 2018-2021
  • Figure 74: India Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 75: India Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 76: Incidences of Neurological Disorders in Australia, 2018-2021
  • Figure 77: Australia Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 78: Australia Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 79: Incidences of Neurological Disorders in South Korea, 2018-2021
  • Figure 80: South Korea Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 81: South Korea Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 82: Rest-of-Asia-Pacific Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 83: Rest-of-Asia-Pacific Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 84: Rest-of-the-World Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 85: Rest-of-the-World Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 86: Rest-of-the-World Robotic Neurosurgery Market, Installed Base, 2023-2035
  • Figure 87: Rest-of-the-World Robotic Neurosurgery Market, Unit Sold, 2023-2035
  • Figure 88: Strategic Initiatives, January 2022-April 2025
  • Figure 89: Data Triangulation
  • Figure 90: Top-Down and Bottom-Up Approach
  • Figure 91: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Competitive Landscape Snapshot
  • Table 3: Robotic Neurosurgery Market Trend Analysis
  • Table 4: Some of the Partnerships and Collaborations in the Global Robotic Neurosurgery Market
  • Table 5: Some of the Product Launch and Regulatory Approvals in the Global Robotic Neurosurgery Market
  • Table 6: FDA Classification Details for Several Prominent Robotic Neurosurgery Systems
  • Table 7: Medical Devices in Japan
  • Table 8: Regulatory Process in RoW
  • Table 9: Costs of Neurosurgery Robotic Systems
  • Table 10: Funding Scenario of Neurosurgery Robotic Systems
  • Table 11: Comparison of Robotic Neurosurgical Procedures Over Conventional Open Surgical Procedures
  • Table 12: Comparison Between Various Navigation Systems Cost Breakdown of Robotic Neurosurgery Systems
  • Table 13: Global Robotic Neurosurgery Market, Robotic Systems (by Company), $Million, 2023-2035
  • Table 14: Global Robotic Neurosurgery Market, Instruments and Accessories (by Company), $Million, 2023-2035
  • Table 15: Global Robotic Neurosurgery Market, Services (by Company), $Million, 2023-2035
  • Table 16: Robotic Neurosurgery Market (by Region), $Million, 2023-2035
  • Table 17: North America Robotic Neurosurgery Market (by Product Type), $Million, 2023-2035
  • Table 18: Incidences of Neurological Disorders in U.S., By Disease Type, 2018-2021
  • Table 19: Incidences of Neurological Disorders in Canada, By Disease Type, 2018-2021
  • Table 20: Europe Robotic Neurosurgery Market (by Product Type), $Million, 2023-2035
  • Table 21: Incidences of Neurological Disorders in Germany, By Disease Type, 2018-2021
  • Table 22: Incidences of Neurological Disorders in France, By Disease Type, 2018-2021
  • Table 23: Incidences of Neurological Disorders in Italy, By Disease Type, 2018-2021
  • Table 24: Incidences of Neurological Disorders in Spain, By Disease Type, 2018-2021
  • Table 25: Incidences of Neurological Disorders in U.K., By Disease Type, 2018-2021
  • Table 26: Asia-Pacific Robotic Neurosurgery Market (by Product Type), $Million, 2023-2035
  • Table 27: Incidences of Neurological Disorders in China, By Disease Type, 2018-2021
  • Table 28: Incidences of Neurological Disorders in Japan, By Disease Type, 2018-2021
  • Table 29: Incidences of Neurological Disorders in India, By Disease Type, 2018-2021
  • Table 30: Incidences of Neurological Disorders in Australia, By Disease Type, 2018-2021
  • Table 31: Incidences of Neurological Disorders in South Korea, By Disease Type, 2018-2021
  • Table 32: Rest-of-the-World Robotic Neurosurgery Market (by Product Type), $Million, 2023-2035
  • Table 33: Global Robotic Neurosurgery Market, Product Benchmarking (by Product)
  • Table 34: Key Strategies, January 2022-April 2025